Covidien (COV) Tops Q1 EPS by 2c

Covidien (NYSE: COV) reported Q1 EPS of $1.05, $0.02 better than the analyst estimate of $1.03. Revenue for the quarter came in at $2.95 billion versus the consensus estimate of $2.9 billion.

For earnings history and earnings-related data on Covidien (COV) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• L3Harris CEO steps down amid conduct review, shares drop
• SanDisk extends rally, Snap faces fresh pressure in premarket trade
• L3Harris names Sam Mehta CEO after Kubasik exits over conduct issues